Samrat Pharmachem Ltd Share Price (530125)
as on
| Source : BSE
Samrat Pharmachem Ltd Stock Performance
as on August 14, 2025 at 4:01 PM IST
Day's Low
Day's High
₹317₹333.9
0.84%
Downside
4.44%
Upside
52 Week's Low
52 Week's High
₹302.05₹6465.52%
Downside
102.06%
Upside
| Market Stats | |
| Previous Close | ₹337.45 |
| Open | ₹329.10 |
| Volume | 7,916.00 |
| Upper Circuit | ₹404.90 |
| Lower Circuit | ₹270.00 |
| Day's Low | ₹317 |
| Day's High | ₹333.9 |
| 52 Week Low | ₹302.05 |
| 52 Week High | ₹646 |
| Returns % | |
| 1 Month Return | -17.29 % |
| 3 Month Return | -16.72 % |
| 1 Year Return | -17.91 % |
| 3 Year Return | -41.64 % |
| 5 Year Return | + 209.14 % |
Samrat Pharmachem Ltd Stock Fundamentals & Key Indicators
Check Samrat Pharmachem Ltd market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
₹98.24 Cr
Return on Equity (ROE)
3.37
PE Ratio (TTM)
0Return on capital employed (ROCE)
4.14
Beta (LTM)
0.66
P/B Ratio
1.59
Dividend Yield
0PEG Ratio
0Quarterly Earnings Growth YOY
-111.11
EPS (TTM)
0Sector
Pharmaceuticals
Book Value
0Technical Analysis
Bearish
View Technical Analysis
Samrat Pharmachem Ltd Stock's Interest Amongst Investors
Samrat Pharmachem Ltd Financial Results
Get the annual and quarterly financial summary of Samrat Pharmachem Ltd, including revenue, profit, loss and more.
Samrat Pharmachem Ltd Earnings and Dividends
View detailed summary of the earnings and dividend history of Samrat Pharmachem Ltd.
Samrat Pharmachem Ltd Earnings Results
Samrat Pharmachem Ltd’s net profit fell -111.11% since last year same period to ₹0.23Cr in the Q1 2025-2026. On a quarterly growth basis, Samrat Pharmachem Ltd has generated 42.5% jump in its net profits since last 3-months.
Read More about Earnings ResultsSamrat Pharmachem Ltd Dividends May,2024
In the quarter ending March 2024, Samrat Pharmachem Ltd has declared dividend of ₹1.00 per share on 30 May 2024 - translating a dividend yield of 0.63%.
Read More about Dividends
Samrat Pharmachem Ltd Stock Shareholding Pattern
View the shareholding pattern breakup of promoters, FIIs, DIIs, and retail investors in Samrat Pharmachem Ltd.
| Investors | Holdings % | Quarterly Trend | 3M change |
|---|---|---|---|
| Promoter Holdings | 49.09% | 0.00 | |
| Foreign Institutions | 0% | 0.00 | |
| Mutual Funds | 0% | 0.00 | |
| Retail Investors | 47.67% | 0.00 | |
| Others | 3.24% | 0.00 |
Samrat Pharmachem Ltd vs Peers
Compare market cap, revenue, PE, and other key metrics of Samrat Pharmachem Ltd with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| NA | 98.24 | 41.83% | 0.00 | 2 | 281 | |
| NA | 138.38 | -10.52% | 0.00 | 12 | 69 | |
| NA | 48.85 | -16.67% | 0.00 | -22 | 104 | |
| NA | 48.17 | 105.43% | 0.00 | -1 | NA | |
| NA | 496.33 | 21.03% | 0.00 | NA | NA |
Samrat Pharmachem Ltd News & Key Events
Latest news and events in one place to help you make informed investing decisions in Samrat Pharmachem Ltd.
Samrat Pharma Reports Decline in Sales and Losses - 10 Jun, 2025
Samrat Pharma's standalone net sales for March 2025 fell by 13.88% year-on-year to Rs 71.20 crore. The company reported a net loss of Rs 0.40 crore, a significant decrease from the previous year's loss. EBITDA also dropped by 98.79%. The stock closed at Rs 348.25, reflecting a -14.70% return over the last six months.
Insights on Samrat Pharmachem Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
NO EFFECTAgainst Peers
In the last 3 years, Torrent Pharmaceuticals Ltd has given 130.2% return, outperforming this stock by 171.9%
- NO EFFECT
Retail Holding Unchanged
Retail Investor holdings remained unchanged at 47.67% of holdings in Jun 2025 quarter
- NO EFFECT
Against Peers
In the last 1 year, Divis Laboratories Ltd has given 32.3% return, outperforming this stock by 50.3%
- NO EFFECT
Promoter Holding Unchanged
Promoters holdings remained unchanged at 49.09% of holdings in Jun 2025 quarter
NEGATIVE IMPACTPrice Dip
In the last 7 days, Samrat Pharma stock has moved down by -5.4%
About Samrat Pharmachem Ltd
Revenue: ₹75.65Cr as on June 2025 (Q1 FY26)
Net Profit: ₹0.23Cr as on June 2025 (Q1 FY26)
Chairperson Name: Lalit Mehta
| Organisation | Samrat Pharmachem Ltd |
| Headquarters | Mumbai |
| Industry | Pharmaceuticals |
| CEO | Lalit Mehta |
| E-voting on shares | Click here to vote |
FAQs
What is Samrat Pharmachem Ltd share price today?
Samrat Pharmachem Ltd share price today stands at ₹319.7, Open: ₹329.1, Previous Close: ₹337.45, High: ₹333.9, Low: ₹317, 52 Week High: ₹646, 52 Week Low: ₹302.05 as on .
How to buy Samrat Pharmachem Ltd shares ?
To buy Samrat Pharmachem Ltd shares, you need to follow these steps:
- Open a Demat account and Trading account on INDmoney
- Fund your Trading account
- Search for 530125 or Samrat Pharmachem Ltd on the INDmoney app to check live prices of the stock
- Click on Buy or SIP to place an order to invest in Samrat Pharmachem Ltd shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.
What is today's traded volume of Samrat Pharmachem Ltd?
Today's traded volume of Samrat Pharmachem Ltd is 7,916.00. Which means that 7,916.00 shares of Samrat Pharmachem Ltd were bought and sold on the stock market during today's trading session.
What is Samrat Pharmachem Ltd's market cap today?
Today's market capitalisation of Samrat Pharmachem Ltd is ₹98.24 Cr. Market cap or market capitalisation is the total value of a company’s outstanding shares in the stock market, calculated by multiplying the current share price by the total number of shares issued by the company.
What is the 52 week high and 52 week low range of Samrat Pharmachem Ltd?
Samrat Pharmachem Ltd’s 52 week high is ₹646 and 52 week low is ₹302.05. The current share price of Samrat Pharmachem Ltd is ₹319.7, which is -50.51% down from its 52 week high and 5.84% up from its 52 week low.